“Recent Disclosure Reveals $40,000 in CHAMPIONX Lobbying Efforts”

Published On: April 19, 2025 3:22 pm

ChampionX Discloses Lobbying Efforts and Insider Trading Activity

A recent filing under the Lobbying Disclosure Act revealed that ChampionX spent $40,000 on lobbying in the first quarter of 2025. This lobbying focused on obtaining certification for technologies used in compliance with regulations on methane emissions detection and monitoring.

Insider Trading Activity for CHX

In the past six months, insiders of ChampionX (ticker: CHX) have executed one trade in the open market. This included no purchases and one sale.

Here is a summary of the recent insider trading transactions for $CHX:

DERIC D. BRYANT sold 49,303 shares, realizing an estimated $1,482,053.

To follow insider transactions, you can explore the Quiver Quantitative insider trading dashboard.

Hedge Fund Activity Surrounding CHX

In the most recent quarter, 189 institutional investors increased their holdings of CHX, while 200 decreased their investments in the same stock.

Here are some significant changes in hedge fund positions:

BESSEMER GROUP INC reduced their holdings by 3,116,262 shares (-99.6%), valued at approximately $84,731,163.
NORGES BANK increased their portfolio by 2,261,744 shares (+490.6%), for an estimated $61,496,819.
CLEARBRIDGE INVESTMENTS, LLC decreased by 1,825,125 shares (-99.3%), losing approximately $49,625,148.
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. reduced their position by 1,240,817 shares (-35.3%), equating to about $33,737,814.
CALAMOS ADVISORS LLC added 1,232,500 shares (+470.4%), valued at an estimated $33,511,675.
MILLENNIUM MANAGEMENT LLC decreased by 1,222,296 shares (-39.1%), for a loss estimated at $33,234,228.
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND increased their position by 1,101,100 shares (+373.1%), valued at approximately $29,938,909.

To follow updates on hedge fund transactions, take a look at Quiver Quantitative’s institutional holdings dashboard.

Analyst Ratings for CHX

In recent months, Wall Street analysts have reviewed $CHX stocks. Currently, one firm has issued a buy recommendation, and no firms have issued sell ratings.

Here is a recent analyst rating:

On February 10, 2025, Piper Sandler issued an “Overweight” rating.

To stay updated on analyst ratings and targets for CHX, check Quiver Quantitative’s forecast page for $CHX.

Projected Price Targets for CHX

Multiple analysts have recently set price targets for $CHX. In the last six months, two analysts have provided projections, with a median price target of $33.5.

Here are the most recent price targets:

Phillip Jungwirth from Loop Capital Markets set a price target of $33.0 on February 10, 2025.
Derek Podhaizer from Piper Sandler set a price target of $34.0 on February 10, 2025.

This article is not financial advice. For more information, visit Quiver Quantitative’s disclaimers.

This article was originally published on Quiver News; read the full story.

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.